Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 158-163

  Wang, Xi ^a   Hutt Fletcher, Lindsey M ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ARTICLE; B LYMPHOCYTE ACTIVATION; ENDOPLASMIC RETICULUM; EPSTEIN BARR VIRUS; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; TARGET CELL; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS INFECTION;

EID: 0031984536     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.158-163.1998     Document Type: Article

References (45)

1. Agius, C. T., and M. J. Studdert. 1994. Equine herpesvirus 2 and 5: comparisons with other members of the subfamily gammaherpesvirinae. Adv. Virus Res. 44:357-379.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1997. Current protocols in molecular biology. John Wiley and Sons, Inc., New York, N.Y.
3. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, S. C. Satchwell, C. Seguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (London) 310:207-211.
4. Davis-Poynter, N., S. Bell, T. Minson, and H. Browne. 1994. Analysis of the contributions of herpes simplex virus type 1 membrane proteins to the induction of cell-cell fusion. J. Virol. 68:7586-7590.
5. Desai, P. J., P. A. Schaffer, and A. C. Minson. 1988. Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity. J. Gen. Virol. 69:1147-1156.
6. Duus, K. M., C. Hatfleld, and C. Grose. 1995. Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology 210:429-440.
7. Fehler, F., J. M. Herrmann, A. Saalmüller, T. C. Mettenleiter, and G. M. Keil. 1992. Glycoprotein IV of bovine herpesvirus 1-expressing cell line complements and rescues a conditionally lethal viral mutant. J. Virol. 66:831-839.
8. Forghani, B., L. Ni, and C. Grose. 1994. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology 199:458-462.
9. Forrester, A., H. Farrell, G. Wilkinson, J. Kaye, N. Davis-Poynter, and T. Minson. 1992. Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J. Virol. 66:341-348.
10. Fuller, A. O., R. E. Santos, and P. G. Spear. 1989. Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. J. Virol. 63:3435-3443.
11. Gompels, U. A., and A. Minson. 1986. The properties and sequence of glycoprotein H of herpes simplex type 1. Virology 153:230-247.
12. Gripon, P., C. Diot, and C. Guguen-Guillouzo. 1993. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effects of polyethylene glycol on adsorption and penetration. Virology 192:534-540.
13. Heineman, T., M. Gong, J. Sample, and E. Kieff. 1988. Identification of the Epstein-Barr virus gp85 gene. J. Virol. 62:1101-1107.
14. Hermann, A., M. J. Clague, and R. Blumenthal. 1993. Enhancement of viral fusion by nonadsorbing polymers. Biophysics 65:528-534.
15. Heston, L., M. Rabson, N. Brown, and G. Miller. 1982. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature (London) 295:160-163.
16. Hoekstra, D., K. Klappe, H. Hoff, and S. Nir. 1989. Mechanism of fusion of Sendai virus: role of hydrophobic interactions and mobility constraints of viral glycoproteins. Effects of polyethylene glycol. J. Biol. Chem. 264:6786-6792.
17. Hoffman, G. J., S. G. Lazarowitz, and S. D. Hayward. 1980. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proc. Natl. Acad. Sci. USA 77:2979-2983.
18. Huber, M. T., and T. Compton. 1997. Characterization of a novel third member of the human cytomegalovirus glycoprotein H-L complex. J. Virol. 71:5391-5398.
19. Hutchinson, L., H. Browne, V. Wargent, N. Davis-Poynter, S. Primorac, K. Goldsmith, A. C. Minson, and D. C. Johnson. 1992. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 66:2240-2250.
20. Hutt-Fletcher, L. M., N. Balachandran, and P. A. LeBlanc. 1986. Modification of Epstein-Barr virus replication by tunicamycin. J. Virol. 57:117-123.
21. Kaye, J. F., U. A. Gompels, and A. C. Minson. 1992. Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J. Gen. Virol. 73:2693-2698.
22. Keller, P. M., A. J. Davison, R. S. Lowe, M. W. Riemen, and R. W. Ellis. 1987. Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus. Virology 157:526-523.
23. Kurilla, M. G., T. Heineman, L. C. Davenport, E. Kieff, and L. M. Hutt-Fletcher. 1995. A novel Epstein-Barr virus glycoprotein gp150 expressed from the BDLF3 open reading frame. Virology 209:108-121.
24. Li, L., J. A. Nelson, and W. J. Britt. Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex. J. Virol. 71:3090-3097.
25. Li, Q. X., M. K. Spriggs, S. Kovats, S. M. Turk, M. R. Comeau, B. Nepom, and L. M. Hutt-Fletcher. 1997. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71:4657-4662.
26. Li, Q. X., S. M. Turk, and L. M. Hutt-Fletcher. 1995. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J. Virol. 69:3987-3994.
27. Liu, D. X., U. A. Gompels, J. Nicholas, and C. Lelliott. 1993. Identification and expression of the human herpesvirus 6 glycoprotein H and interaction with an accessory 40K glycoprotein. J. Gen. Virol. 74:1847-1857.
28. Liu, D. X., U. A. Gompels, L. Foa-Tomasi, and G. Campadelli-Fiumi. 1993. Human herpesvirus 6 glycoprotein H and L homologues are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Virology 197:12-22.
29. Miller, N., and L. M. Hutt-Fletcher. 1988. A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus. J. Virol. 62:2366-2372.
30. Nemerow, G. R., and N. R. Cooper. 1981. Isolation of Epstein-Barr virus and studies of its neutralization by human IgG and complement. J. Immunol. 127:272-278.
31. Oba, D. E., and L. M. Hutt-Fletcher. 1988. Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame. J. Virol. 62:1108-1114.
32. Peeters, B., N. Dewind, R. Broer, A. Gielkins, and R. Moormann. 1992. Glycoprotein H of pseudorabies virus is essential for entry and cell-to-cell spread of the virus. J. Virol. 66:3888-3892.
33. Pulvertaft, R. J. V. 1964. Cytology of Burkitt's tumor (African lymphoma). Lancet i:238-240.
34. Rasmussen, L., S. Resta, and T. C. Merigan. 1991. Human cytomegalovirus glycoprotein-receptor interactions. Transplant. Proc. 23 Part 3, no. 3):60-63.
35. Roop, C., L. Hutchinson, and D. C. Johnson. 1993. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J. Virol. 67:2285-2297.
36. Shimizu, N., A. Tanabe-Tochikura, Y. Kuroiwa, and K. Takada. 1994. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68:6069-6073.
37. Shimizu, N., H. Yoshiyama, and K. Takada. 1996. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J. Virol. 70:7260-7263.
38. Spaete, R. R., K. Perot, P. I. Scott, J. A. Nelson, M. F. Stinski, and C. Pachl. 1993. Co-expression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology 193:853-861.
39. Spriggs, M. K., R. J. Armitage, M. R. Comeau, L. Strockbine, T. Farrah, B. MacDuff, D. Ulrich, M. R. Alderson, J. Müllberg, and J. I. Cohen. 1996. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR β chain and inhibits antigen presentation. J. Virol. 70:5557-5563.
40. Strnad, B. C., T. Schuster, R. Klein, R. F. Hopkins III, T. Witmer, R. H. Neubauer, and H. Rabin. 1982. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. J. Virol. 41:258-264.
41. Takada, K. 1984. Cross-linking of cell surface immunoglobulin induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33:27-32.
42. Takada, K., K. Horinouchi, Y. Ono, T. Aya, T. Osato, M. Takahashi, and S. Hayasaka. 1991. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147-156.
43. Telford, E. A., M. S. Watson, H. C. Aird, J. Perry, and A. J. Davison. 1995. The DNA sequence of equine herpesvirus 2. J. Mol. Biol. 249:520-528.
44. Vik, D. P., and D. T. Fearon. 1985. Neutrophils express a receptor for iC3b, C3dg and C3d that is distinct from CR1, CR2 and CR3. J. Immunol. 134:2571-2579.
45. Yaswen, L. R., E. B. Stephens, L. C. Davenport, and L. M. Hutt-Fletcher. 1993. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 195:387-396.